CD274 and neoplasm: A combination of chemoradiation with PD-1/PD-L1 inhibitors showed benefits in clinical trials for other tumor entities, including non-small-cell lung (KEYNOTE-189, NCT02578680), and is a promising approach for the treatment of cervical cancer.